BIOSTAR PHARMACEUTICALS, INC. BSPM Income Statement

Biostar pharmaceuticals, inc. (BSPM)

Income statement / Quarterly

Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
Sales, net
0	0	0	317	644	620	801	1,838	4,206	14,176	6,908	14,385	14,651	19,198	13,181	10,976	15,009	14,650	12,091	15,289	9,969	8,159	15,899
Cost of sales
0	0	0	354	336	321	456	1,070	3,390	8,237	3,327	7,606	7,674	9,931	5,928	5,803	8,068	7,771	5,403	6,087	4,729	3,586	5,063
Gross profit
0	0	0	-36	308	298	344	768	816	5,938	3,581	6,778	6,977	9,267	7,253	5,173	6,941	6,879	6,688	9,202	5,239	4,573	10,836
Advertising expenses
-	-	-	-	-	-	-	-64	0	2,491	1,377	2,196	2,290	2,318	1,788	2,193	931	2,550	1,886	2,839	4,077	4,389	2,848
Selling expenses
14	12	273	265	290	290	323	389	835	2,310	1,299	3,258	2,161	2,537	1,934	1,609	2,584	2,621	2,197	6,551	1,932	2,343	2,907
General and administrative expenses
558	1,515	766	713	488	539	690	2,006	682	1,183	775	3,048	1,651	1,690	1,328	1,687	1,867	1,458	1,077	826	2,640	1,383	1,100
Impairment loss on intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	238	-	-	-	-	-
Provision for doubtful debt
0	0	-53	-8,086	1,491	6,329	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Compensation paid to customers - note 14)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	7,904	-
Administrative penalty - note 14)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,596	-	-
Research and development expenses
-	-	-	-	-	-	-	977	998	1,026	1,018	691	690	689	694	816	811	805	796	2,105	789	789	791
Impairment loss on loan receivables
-	-	-	-	-	-	-	-	-	-	-	-3,845	0	1,576	2,269	-	-	-	-	-	-	-	-
Impairment loss on intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-
Total operating expenses
573	1,528	1,039	-5,963	2,270	7,159	1,013	20,861	2,517	7,011	4,471	7,967	6,793	8,812	8,016	5,347	6,195	7,674	5,957	16,142	11,035	16,810	7,648
Loss from operations
-573	-1,528	-1,039	5,926	-1,961	-6,860	-668	-20,093	-1,701	-1,073	-889	-1,188	183	455	-763	-174	745	-794	731	-6,940	-5,795	-12,237	3,187
Interest income
0	0	1	1	0	0	0	-	311	-	-	369	309	334	316	209	348	331	455	48	55	96	95
Interest expense
47	45	45	62	105	0	38	220	0	1	61	154	0	0	0	74	98	99	95	51	1	17	15
Fair value adjustment on warrants
12	259	16	180	2	16	28	99	144	90	-9	236	-51	393	0	-	0	0	-	-	-	-	-
Other expense
-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	2	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income
482	0	-	-	501	0	-	-	0	320	322	-5	0	0	1,099	-	-	-	0	0	0	0	0
Other income (expense), net
-	-	-	-	-	-	-	-	-	-	-	-	45	-4	-	-	0	0	-	-	-	-	-
Other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	46	-	-	-	2	-	-	-	-
Total other income, net
448	213	25	114	398	16	-10	-1,154	456	411	251	451	303	723	1,369	1,307	250	232	357	-2	54	79	80
Loss before income taxes
-125	-1,314	-1,014	6,041	-1,563	-6,844	-678	-21,247	-1,244	-661	-638	-737	486	1,178	605	1,133	996	-562	1,088	-6,942	-5,741	-12,158	3,268
Income tax expenses
0	0	0	2,653	0	58	-58	1,957	10	-169	-478	-3,393	247	-466	299	541	608	168	527	-200	198	-2,676	1,101
Net loss
-125	-1,314	-1,014	3,388	-1,563	-6,902	-620	-23,205	-1,254	-492	-160	2,656	239	1,645	306	591	387	-730	560	-6,742	-5,939	-9,482	2,167
Foreign currency translation adjustment
786	618	316	-1,601	-174	-1,287	309	-478	-3,140	279	381	167	58	98	-533	-	1,336	942	437	365	-117	42	255
Comprehensive loss
661	-695	-697	1,786	-1,737	-8,189	-311	-23,683	-4,394	-212	220	2,824	298	1,744	-227	-53	1,724	211	998	-6,376	-6,056	-9,439	2,422
Net loss per share
Basic (in Dollars per share)
-0.05	-0.50	-0.38	1.61	-0.71	-3.12	-0.28	-10.54	-0.57	-0.22	-0.07	2.15	0.02	0.11	0.02	0.04	0.03	-0.06	0.06	-	-	-	-
Diluted (in Dollars per share)
-0.05	-0.50	-0.38	1.61	-0.71	-3.12	-0.28	-10.54	-0.57	-0.22	-0.07	2.15	0.02	0.11	0.02	0.04	0.03	-0.06	0.06	-	-	-	-
Weighted average number of common shares outstanding
Basic (in Shares)
2,637	2,637	2,637	2,556	2,210	2,210	2,210	2,210	2,210	2,210	2,210	-34,353	15,288	14,326	13,024	12,464	12,024	11,560	9,993	-	-	-	-
Diluted (in Shares)
2,637	2,637	2,637	2,556	2,210	2,210	2,210	2,210	2,210	2,210	2,210	-34,359	15,288	14,326	13,030	12,464	12,024	11,560	9,993	-	-	-	-
Net income (loss) per share Basic and diluted (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.68	-0.63	-1.01	0.23
Weighted average number of common shares outstanding Basic and diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,993	9,490	9,400	9,398